Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort

被引:12
作者
Grewal, Japnam S. [1 ]
Carlsten, Christopher [1 ]
Johnston, James C. [1 ]
Shah, Aditi S. [1 ]
Wong, Alyson W. [1 ,2 ]
Ryerson, Christopher J. [1 ,2 ]
机构
[1] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[2] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada
关键词
COVID-19; Dyspnea; Patient; Outcomes; Predictors; AMERICAN-SOCIETY; ECHOCARDIOGRAPHY; STANDARDIZATION; RECOMMENDATIONS; QUANTIFICATION; SURVIVORS; UPDATE; LIFE;
D O I
10.1186/s12890-023-02376-w
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundThe pathophysiology, evolution, and associated outcomes of post-COVID dyspnea remain unknown. The aim of this study was to determine the prevalence, severity, and predictors of dyspnea 12 months following hospitalization for COVID-19, and to describe the respiratory, cardiac, and patient-reported outcomes in patients with post-COVID dyspnea.MethodsWe enrolled a prospective cohort of all adult patients admitted to 2 academic hospitals in Vancouver, Canada with PCR-confirmed SARS-CoV-2 during the first wave of COVID between March and June 2020. Dyspnea was measured 3, 6, and 12 months after initial symptom onset using the University of California San Diego Shortness of Breath Questionnaire.ResultsA total of 76 patients were included. Clinically meaningful dyspnea (baseline score > 10 points) was present in 49% of patients at 3 months and 46% at 12 months following COVID-19. Between 3 and 12 months post-COVID-19, 24% patients had a clinically meaningful worsening in their dyspnea, 49% had no meaningful change, and 28% had a clinically meaningful improvement in their dyspnea. There was worse sleep, mood, quality of life, and frailty in patients with clinically meaningful dyspnea at 12 months post-COVID infection compared to patients without dyspnea. There was no difference in PFT findings, troponin, or BNP comparing patients with and without clinically meaningful dyspnea at 12 months. Severity of dyspnea and depressive symptoms at 3 months predicted severity of dyspnea at 12 months.ConclusionsPost-COVID dyspnea is common, persistent, and negatively impacts quality of life. Mood abnormalities may play a causative role in post-COVID dyspnea in addition to potential cardiorespiratory abnormalities. Dyspnea and depression at initial follow-up predict longer-term post-COVID dyspnea, emphasizing that standardized dyspnea and mood assessment following COVID-19 may identify patients at high risk of post-COVID dyspnea and facilitating early and effective management.
引用
收藏
页数:9
相关论文
共 29 条
[1]   Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers [J].
Azzolini, Elena ;
Levi, Riccardo ;
Sarti, Riccardo ;
Pozzi, Chiara ;
Mollura, Maximiliano ;
Mantovani, Alberto ;
Rescigno, Maria .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (07) :676-678
[2]   Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls [J].
Beaudry, Rhys I. ;
Brotto, Andrew R. ;
Varughese, Rhea A. ;
de Waal, Stephanie ;
Fuhr, Desi P. ;
Damant, Ronald W. ;
Ferrara, Giovanni ;
Lam, Grace Y. ;
Smith, Maeve P. ;
Stickland, Michael K. .
FRONTIERS IN PHYSIOLOGY, 2022, 13
[3]   THE PITTSBURGH SLEEP QUALITY INDEX - A NEW INSTRUMENT FOR PSYCHIATRIC PRACTICE AND RESEARCH [J].
BUYSSE, DJ ;
REYNOLDS, CF ;
MONK, TH ;
BERMAN, SR ;
KUPFER, DJ .
PSYCHIATRY RESEARCH, 1989, 28 (02) :193-213
[4]   Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease [J].
Chen, Tao ;
Tsai, Amy Po Yu ;
Hur, Seo Am ;
Wong, Alyson W. ;
Sadatsafavi, Mohsen ;
Fisher, Jolene H. ;
Johannson, Kerri A. ;
Assayag, Deborah ;
Morisset, Julie ;
Shapera, Shane ;
Khalil, Nasreen ;
Fell, Charlene D. ;
Manganas, Helene ;
Cox, Gerard ;
To, Teresa ;
Gershon, Andrea S. ;
Hambly, Nathan ;
Halayko, Andrew J. ;
Wilcox, Pearce G. ;
Kolb, Martin ;
Ryerson, Christopher J. .
RESPIRATORY RESEARCH, 2021, 22 (01)
[5]   Validation of a new dyspnea measure - The UCSD shortness of breath questionnaire [J].
Eakin, EG ;
Resnikoff, PM ;
Prewitt, LM ;
Ries, AL ;
Kaplan, RM .
CHEST, 1998, 113 (03) :619-624
[6]   Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study [J].
Gloeckl, Rainer ;
Leitl, Daniela ;
Jarosch, Inga ;
Schneeberger, Tessa ;
Nell, Christoph ;
Stenzel, Nikola ;
Vogelmeier, Claus F. ;
Kenn, Klaus ;
Koczulla, Andreas R. .
ERJ OPEN RESEARCH, 2021, 7 (02)
[7]   Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement [J].
Graham, Brian L. ;
Steenbruggen, Irene ;
Barjaktarevic, Igor Z. ;
Cooper, Brendan G. ;
Hall, Graham L. ;
Hallstrand, Teal S. ;
Kaminsky, David A. ;
McCarthy, Kevin ;
McCormack, Meredith C. ;
Miller, Martin R. ;
Oropez, Cristine E. ;
Rosenfeld, Margaret ;
Stanojevic, Sanja ;
Swanney, Maureen P. ;
Thompson, Bruce R. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (08) :E70-E88
[8]   2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung [J].
Graham, Brian L. ;
Brusasco, Vito ;
Burgos, Felip ;
Cooper, Brendan G. ;
Jensen, Robert ;
Kendrick, Adrian ;
MacIntyre, Neil R. ;
Thompson, Bruce R. ;
Wanger, Jack .
EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (01)
[9]   One-year outcomes in survivors of the acute respiratory distress syndrome [J].
Herridge, MS ;
Cheung, AM ;
Tansey, CM ;
Matte-Martyn, A ;
Diaz-Granados, N ;
Al-Saidi, F ;
Cooper, AB ;
Guest, CB ;
Mazer, CD ;
Mehta, S ;
Stewart, TE ;
Barr, A ;
Cook, D ;
Slutsky, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (08) :683-693
[10]  
Huang CL, 2023, LANCET, V401, pE21, DOI [10.1016/S0140-6736(23)00810-3, 10.1016/S0140-6736(20)32656-8]